| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $67.4M | $302.3M | $257.3M |
| YoY Revenue Growth % | -77.7% | +17.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$176.1M | $81.6M | $173.7M |
| Operating Margin % | -80.0% | 27.0% | 67.5% |
| Net Income (GAAP) | -$177.0M | $66.1M | $139.8M |
| EBITDA (Normalized) | -$172.7M | $92.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$166.9M | -$199.3M | -$31.3M |
| Capital Expenditures (CapEx) | $4.2M | $13.0M | — |
| Free Cash Flow (FCF) | -$171.1M | -$212.3M | -$31.3M |
| FCF Margin % | -80.0% | -70.2% | -12.2% |
| Return on Invested Capital (ROIC %) | -45.0% | 68.0% | — |
| Cash & Short-Term Equivalents | $26.3M | $114.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $54.5M | $209.7M | — |